Ono Pharmaceutical Co., Ltd.
OPHLF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $204,567,000 | $166,141,000 | $96,135,000 | $69,112,000 |
| Short-Term Investments | $5,813,000 | $38,454,000 | $68,154,000 | $47,857,000 |
| Receivables | $135,022,000 | $136,066,000 | $114,396,000 | $99,788,000 |
| Inventory | $74,864,000 | $48,629,000 | $44,814,000 | $41,817,000 |
| Other Curr. Assets | $34,838,000 | $24,306,000 | $21,602,000 | $22,692,000 |
| Total Curr. Assets | $455,104,000 | $413,596,000 | $345,101,000 | $281,266,000 |
| Property Plant & Equip (Net) | $105,721,000 | $104,752,000 | $108,420,000 | $112,131,000 |
| Goodwill | $21,186,000 | $0 | $0 | $0 |
| Intangibles | $330,041,000 | $57,288,000 | $69,134,000 | $64,734,000 |
| Long-Term Investments | $88,558,000 | $294,375,000 | $252,710,000 | $204,599,000 |
| Tax Assets | $51,020,000 | $0 | $35,604,000 | $25,074,000 |
| Other NC Assets | $12,416,000 | $43,657,000 | $71,468,000 | $51,399,000 |
| Total NC Assets | $608,942,000 | $500,072,000 | $537,336,000 | $457,937,000 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,064,046,000 | $913,668,000 | $882,437,000 | $739,203,000 |
| Liabilities | – | – | – | – |
| Payables | $89,329,000 | $60,691,000 | $66,794,000 | $49,689,000 |
| Short-Term Debt | $33,178,000 | $2,310,000 | -$32,746,000 | $59,000 |
| Tax Payable | $4,058,000 | $22,093,000 | $34,575,000 | $1,526,000 |
| Deferred Revenue | $0 | $0 | $35,236,000 | $2,242,000 |
| Other Curr. Liab. | $21,731,000 | $18,530,000 | $19,070,000 | $12,410,000 |
| Total Curr. Liab. | $148,296,000 | $103,624,000 | $122,929,000 | $65,926,000 |
| LT Debt | $113,500,000 | $6,552,000 | $6,678,000 | $6,501,000 |
| Deferred Rev, NC | $0 | $0 | $3,350,000 | $3,322,000 |
| Deferred Tax Liab, NC | $10,817,000 | $1,013,000 | $983,000 | $1,009,000 |
| Other NC Liab. | $3,231,000 | $3,874,000 | $0 | $0 |
| Total NC Liab. | $127,548,000 | $11,439,000 | $11,695,000 | $11,603,000 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $11,678,000 | $8,862,000 | $9,168,000 | $8,802,000 |
| Total Liabilities | $275,844,000 | $115,063,000 | $134,624,000 | $77,529,000 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $17,358,000 | $17,358,000 | $17,358,000 | $17,358,000 |
| Retained Earnings | $790,908,000 | $768,183,000 | $709,890,000 | $644,754,000 |
| AOCI | $19,790,000 | $53,195,000 | $51,702,000 | $51,236,000 |
| Other Equity | -$45,605,000 | -$45,775,000 | -$37,081,000 | -$57,442,000 |
| Total Equity | $782,451,000 | $792,961,000 | $741,869,000 | $655,906,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $5,751,000 | $5,644,000 | $5,944,000 | $5,768,000 |
| Total Liab. & Tot. Equity | $1,064,046,000 | $913,668,000 | $882,437,000 | $739,203,000 |
| Net Debt | -$57,889,000 | -$157,279,000 | -$122,203,000 | -$62,552,000 |